Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal dopamine synthesis from precursors.

M Barthelmebs1, B Vailly, J Velly

  • 1Institut de Pharmacologie, URA D0589 CNRS, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France.

American Journal of Hypertension
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanding the Distinctive Neuroimaging Phenotype of <i>ACTA2</i> Mutations.

AJNR. American journal of neuroradiology·2018
Same author

Early experience with a split-bolus single-pass CT protocol in paediatric trauma.

Clinical radiology·2017
Same author

Fat-free mass loss generated with weight loss in overweight and obese adults: What may we expect?

Diabetes, obesity & metabolism·2014
Same author

LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma.

Oncogene·2010
Same author

Gamma hydroxybutyrate distribution and turnover rates in discrete brain regions of the rat.

Neurochemistry international·2010
Same author

Peritoneal dialysis in children: consider the membrane for optimal prescription.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia·2008
Same journal

Efficacy and Safety of Baxdrostat in the Management of Uncontrolled Hypertension: A Systematic Review and Meta-Analysis.

American journal of hypertension·2026
Same journal

Hemodynamic Evolution of Heart Failure from Hypertension: Lower Stroke Volume Index and Higher Heart Rate.

American journal of hypertension·2026
Same journal

Opposite Seasonal Variation in Nighttime and Morning Blood Pressure: A Longitudinal Study of Patients with Hypertension.

American journal of hypertension·2026
Same journal

Screening for Postprandial Hypotension: The Importance of Home Blood Pressure Monitoring.

American journal of hypertension·2026
Same journal

Distinct Mediating Roles of Hypertension in Arterial Stiffness Mechanisms Associated with Cardiovascular Disease Risk: A Community-Based Cohort Study.

American journal of hypertension·2026
Same journal

Long-term systolic blood pressure time in target and risk of cardiovascular events in older adults: a secondary analysis of the ASPREE cohort.

American journal of hypertension·2026
See all related articles

Levodopa (L-dopa) acts as a kidney-specific prodrug, significantly increasing urinary dopamine excretion without systemic effects. This suggests L-dopa

Area of Science:

  • Pharmacology
  • Nephrology
  • Neuroscience

Background:

  • Dopamine (DA) plays a crucial role in regulating renal function.
  • Levodopa (L-dopa) is a precursor to dopamine, commonly used for Parkinson's disease.
  • The potential of L-dopa as a kidney-directed prodrug is not fully understood.

Purpose of the Study:

  • To investigate L-dopa's characteristics as a kidney-directed dopamine prodrug.
  • To examine the effects of L-dopa on renal function and dopamine synthesis in vivo and in vitro.
  • To determine the role of endorenal dopamine synthesis and DA-1 receptor stimulation in L-dopa's renal effects.

Main Methods:

  • Administered L-dopa subcutaneously to Wistar rats and measured urinary dopamine excretion.
  • Assessed systemic effects on blood pressure and heart rate.

Related Experiment Videos

  • In anesthetized rats, evaluated L-dopa's impact on natriuresis, diuresis, and renal blood flow, using carbidopa and SCH 23390 as inhibitors.
  • Utilized isolated perfused rat kidneys to compare dopamine synthesis from L-dopa and gludopa.
  • Investigated L-dopa metabolism in nonfiltering kidneys with restricted dopa decarboxylase access.

    • Main Results:

    • Subcutaneous L-dopa administration resulted in a 450-fold increase in 24-hour urinary dopamine excretion without affecting systemic blood pressure or heart rate.
    • In vivo, L-dopa enhanced natriuresis, diuresis, and renal blood flow, effects abolished by carbidopa and SCH 23390, indicating dependence on endorenal dopamine synthesis and DA-1 receptor activation.
    • In isolated perfused kidneys, L-dopa yielded more dopamine than gludopa, and its metabolism was not hindered by restricted access to dopa decarboxylase on the basolateral membrane.

    Conclusions:

    • L-dopa functions as a kidney-directed dopamine prodrug, increasing renal dopamine levels without systemic side effects.
    • The observed renal effects of L-dopa are mediated by endogenously synthesized dopamine acting on DA-1 receptors.
    • L-dopa demonstrates efficient renal synthesis of dopamine, outperforming gludopa, particularly under conditions limiting enzyme access.